{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:00:30Z","timestamp":1792569630313,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015362","name":"Amicus Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.ijcard.2021.07.022","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T02:19:13Z","timestamp":1626401953000},"page":"110-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["ECG-based score estimates the probability to detect Fabry Disease cardiac involvement"],"prefix":"10.1016","volume":"339","author":[{"given":"Stefano","family":"Figliozzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Camporeale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Boveri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Pieruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Pieroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Lusardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Spada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Mignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Graziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Tondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelvin","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Namdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2021.07.022_bb0005","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM196705252762101","article-title":"Enzymatic defect in Fabry\u2019s disease","author":"Brady","year":"1967","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2014.06.019","article-title":"Relation of burden of myocardial fibrosis to malignant ventricular arrhythmias and outcomes in fabry disease","author":"Kr\u00e4mer","year":"2014","journal-title":"Am J Cardiol Published Online First"},{"key":"10.1016\/j.ijcard.2021.07.022_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: management and treatment recommendations for adult patients","author":"Ortiz","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2018.03.020","article-title":"Proposed stages of myocardial phenotype development in Fabry disease","author":"Nordin","year":"2019","journal-title":"JACC Cardiovasc. Imag."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0025","doi-asserted-by":"crossref","DOI":"10.1080\/10976640600605002","article-title":"The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease","author":"Moon","year":"2006","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0030","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jacc.2020.12.024","article-title":"Cardiac involvement in Fabry disease: JACC review topic of the week","volume":"77","author":"Pieroni","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0035","article-title":"Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2 and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imagin","author":"Messroghli","year":"2017","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.112.000070","article-title":"Identification and assessment of Anderson-fabry disease by cardiovascular magnetic resonance noncontrast myocardial T1 mapping","author":"Sado","year":"2013","journal-title":"Circ. Cardiovasc. Imag."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0045","doi-asserted-by":"crossref","DOI":"10.1186\/s12968-014-0099-4","article-title":"Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance","author":"Pica","year":"2014","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0050","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.118.008424","article-title":"Predictors of clinical evolution in prehypertrophic Fabry disease","author":"Camporeale","year":"2019","journal-title":"Circ. Cardiovasc. Imag."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0055","article-title":"The myocardial phenotype of Fabry disease pre-hypertrophy and pre-detectable storage","author":"Augusto","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Imag."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0065","doi-asserted-by":"crossref","DOI":"10.1093\/ehjci\/jey132","article-title":"Multimodality imaging in Fabry cardiomyopathy: from early diagnosis to therapeutic targets","author":"Militaru","year":"2018","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2021.07.022_bb0070","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1093\/eurheartj\/ehs166","article-title":"Left ventricular hypertrophy in Fabry disease: a practical approach to diagnosis","volume":"34","author":"Yousef","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0075","article-title":"2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy","author":"Elliott","year":"2015","journal-title":"Russ. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2011.09.052","article-title":"Value of electrocardiogram in the differentiation of hypertensive heart disease, hypertrophic cardiomyopathy, aortic stenosis, amyloidosis, and fabry disease","author":"Namdar","year":"2012","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/hrt.2010.211789","article-title":"Electrocardiographic changes in early recognition of Fabry disease","author":"Namdar","year":"2011","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2021.07.022_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2009.10.056","article-title":"PQ interval in patients with Fabry disease","author":"Namdar","year":"2010","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0095","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.105.595892","article-title":"Significance of a fragmented QRS complex versus a Q wave in patients with coronary artery disease","author":"Das","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2021.07.022_bb0100","doi-asserted-by":"crossref","DOI":"10.1111\/j.1542-474X.1997.tb00325.x","article-title":"An analysis of the time-relations of electrocardiograms","author":"Bazett","year":"1997","journal-title":"Ann. Noninvas. Electrocardiol."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0105","series-title":"Computer Intensive Statistical Methods: Validation Model Selection and Bootstrap","author":"Hjorth","year":"2017"},{"key":"10.1016\/j.ijcard.2021.07.022_bb0110","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM197308162890709","article-title":"The abbreviated Pr interval of Fabry\u2019s disease","author":"Roudebush","year":"1973","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0115","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007168","article-title":"Cardiac phenotype of prehypertrophic fabry disease","author":"Nordin","year":"2018","journal-title":"Circ. Cardiovasc. Imag."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9149(94)90106-6","article-title":"Electrophysiologic findings in Fabry\u2019s disease with a short PR interval","author":"Pochis","year":"1994","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-035182","article-title":"Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative","volume":"10","author":"Hughes","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcard.2021.07.022_bb0130","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/ejhf.1960","article-title":"An expert consensus document on the management of cardiovascular manifestations of Fabry disease","volume":"22","author":"Linhart","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0135","doi-asserted-by":"crossref","DOI":"10.2353\/ajpath.2008.070576","article-title":"Myofilament degradation and dysfunction of human cardiomyocytes in fabry disease","author":"Chimenti","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2020.05.011","article-title":"Atrial dysfunction assessed by cardiac magnetic resonance as an early marker of Fabry cardiomyopathy","volume":"13","author":"Bernardini","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2021.07.022_bb0145","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.114.002569","article-title":"Pathology and function of conduction tissue in Fabry disease cardiomyopathy","author":"Frustaci","year":"2015","journal-title":"Circ. Arrhythmia Electrophysiol."},{"key":"10.1016\/j.ijcard.2021.07.022_bb0150","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.stemcr.2019.07.004","article-title":"A human stem cell model of Fabry disease implicates LIMP-2 accumulation in cardiomyocyte pathology","volume":"13","author":"Birket","year":"2019","journal-title":"Stem Cell Rep."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321011670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527321011670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:55:06Z","timestamp":1759092906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527321011670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":30,"alternative-id":["S0167527321011670"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.07.022","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ECG-based score estimates the probability to detect Fabry Disease cardiac involvement","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2021.07.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}